Nalaganje...
The Clinical Benefits of Dutasteride Treatment for LUTS and BPH
Dutasteride is the first dual inhibitor of both 5α-reductase Types 1 and 2 isoenzymes, with efficacy and safety proven in 3 randomized placebo-controlled trials, each 2 years in duration. The current report demonstrates that longer-term treatment over 48 months with dutasteride results in continuing...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MedReviews, LLC
2004
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1472913/ https://ncbi.nlm.nih.gov/pubmed/16985921 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|